ABME (@abmejournal) 's Twitter Profile
ABME

@abmejournal

News from the flagship journal of BMES covering all biomedical engineering topics; Annual Best Paper Awards for students, post-docs, and faculty.

ID: 914910595727622144

linkhttp://www.springer.com/biomed/journal/10439 calendar_today02-10-2017 17:50:59

1,1K Tweet

2,2K Followers

112 Following

ABME (@abmejournal) 's Twitter Profile Photo
ABME
@abmejournal

a month ago

Breathing shouldn’t be a battle, but for those with idiopathic pulmonary fibrosis (IPF), it often is. To improve the lives of patients living with this progressive, deadly lung disease, researchers explored a new way to deliver two leading IPF medications – Nintedanib (NTB) and

Breathing shouldn’t be a battle, but for those with idiopathic pulmonary fibrosis (IPF), it often is. To improve the lives of patients living with this progressive, deadly lung disease, researchers explored a new way to deliver two leading IPF medications – Nintedanib (NTB) and